BlackRock Fund Advisors’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $3.26M | Sell |
1,280,030
-418,434
| -25% | -$1.07M | ﹤0.01% | 3060 |
|
|
2016
Q3 | $5.25M | Buy |
1,698,464
+137,032
| +9% | +$423K | ﹤0.01% | 2823 |
|
|
2016
Q2 | $5.01M | Buy |
1,561,432
+52,481
| +3% | +$168K | ﹤0.01% | 2805 |
|
|
2016
Q1 | $4.68M | Buy |
1,508,951
+52,051
| +4% | +$161K | ﹤0.01% | 2778 |
|
|
2015
Q4 | $5.84M | Sell |
1,456,900
-106,665
| -7% | -$428K | ﹤0.01% | 2752 |
|
|
2015
Q3 | $7.16M | Buy |
1,563,565
+54,956
| +4% | +$252K | ﹤0.01% | 2572 |
|
|
2015
Q2 | $7.83M | Sell |
1,508,609
-61,159
| -4% | -$317K | ﹤0.01% | 2645 |
|
|
2015
Q1 | $9.83M | Buy |
1,569,768
+17,524
| +1% | +$110K | ﹤0.01% | 2454 |
|
|
2014
Q4 | $9.76M | Buy |
1,552,244
+146,971
| +10% | +$924K | ﹤0.01% | 2472 |
|
|
2014
Q3 | $8.54M | Buy |
1,405,273
+6,199
| +0.4% | +$37.7K | ﹤0.01% | 2448 |
|
|
2014
Q2 | $9.22M | Buy |
1,399,074
+100,506
| +8% | +$662K | ﹤0.01% | 2470 |
|
|
2014
Q1 | $30.9M | Buy |
1,298,568
+55,098
| +4% | +$1.31M | 0.01% | 1743 |
|
|
2013
Q4 | $13.3M | Sell |
1,243,470
-15,089
| -1% | -$161K | ﹤0.01% | 2213 |
|
|
2013
Q3 | $16.8M | Buy |
1,258,559
+164,302
| +15% | +$2.19M | 0.01% | 2059 |
|
|
2013
Q2 | $14.4M | Buy |
+1,094,257
| New | +$14.4M | 0.01% | 2043 |
|